Targeting Tumour-Initiating Cells with TRAIL Based Combination Therapy Ensures Complete and Lasting Eradication of Multiple Myeloma Tumours In Vivo

Multiple myeloma (MM) remains an incurable disease despite improvements to available treatments and efforts to identify new drug targets. Consequently new approaches are urgently required. We have investigated the potential of native tumour necrosis factor-related apoptosis-inducing ligand (TRAIL),...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitovski, Srdjan, Chantry, Andrew D., Lawson, Michelle A., Croucher, Peter I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353958/
https://www.ncbi.nlm.nih.gov/pubmed/22615740
http://dx.doi.org/10.1371/journal.pone.0035830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353958/
https://www.ncbi.nlm.nih.gov/pubmed/22615740
http://dx.doi.org/10.1371/journal.pone.0035830

Ejemplares similares